Replies to post #238 on Argent Biopharma Ltd (MGCLF)

[BostonErin]

She’s also in the medical field (I’ll let her decide what she wants to post publicly). I still like Auscan but MGC will have so many revenue streams. I know that Canopy Growth has been using their successful business plan to educate doctors in Australia regarding cannabis prescriptions. This will be so beneficial to MGC, since they are first to market with Cannepil. From what I read Canopy learned from training docs in Canada, the process should be fast tracked in Australia and they started in 2017

I’m MGC nutraceuticals line, they have a product to help with chemo side effects- this you won’t need a prescription for. The nutraceuticals line could be the most profitable segment from MGC. They are the first Pharmaceutical company to release such a line. A GMP cert is just a lot of delicious icing on this cake